Precigen, Inc. (PGEN) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Precigen, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.136 Good evening, and welcome to the President's Full Year 2024 00:00:05.136 -- 00:00:09.501 Financial Results and Business Update Call. 00:00:09.501 -- 00:00:14.206 At this time, all lines are in listen-only mode. 00:00:14.206 -- 00:00:19.670 Following the prepared remarks, there will be a question and answer session. 00:00:19.752 -- 00:00:23.894 Please note that this event is being recorded. 00:00:23.936 -- 00:00:29.585 I would now like to turn the conference over to Steve Harrison, from Investor Relations. 00:00:29.585 -- 00:00:32.026 Please go ahead. 00:00:32.209 -- 00:00:35.914 Thank you, Alan, and thank you for everyone joining us this afternoon. 00:00:35.914 -- 00:00:41.181 With me today are Dr. Helen Sabzavary, President and CEO of Precision, Harry 00:00:41.181 -- 00:00:46.589 Tomasian, our CFO, Phil Tennant, our Chief Commercial Officer, and Ritul 00:00:46.589 -- 00:00:51.656 Shah, our Chief Operating Officer. Before we begin, let me briefly review our 00:00:51.656 -- 00:00:56.122 forward-looking statements. During today's call, we will make various forward-looking 00:00:56.122 -- 00:01:00.109 statements. Investors are cautioned that our forward-looking statements are based on 00:01:00.109 -- 00:01:04.916 current expectations and are subject to risks and uncertainties that could cause actual 00:01:04.916 -- 00:01:10.424 results or outcomes to differ from those indicated by our forward-looking statements. 00:01:10.424 -- 00:01:15.251 Please read the safe-hour statement contained in our most recent SEC filings, 00:01:15.251 -- 00:01:19.417 as well as risk factors contained in precedent filings. 00:01:19.417 -- 00:01:22.060 With that, I would like to now turn the call over to Dr. 00:01:22.060 -- 00:01:24.068 Sabzabari. Helen? 00:...